Core Laboratories Inc. $CLB Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC trimmed its position in shares of Core Laboratories Inc. (NYSE:CLB) by 32.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 121,451 shares of the oil and gas company’s stock after selling 57,334 shares during the quarter. Rice Hall James & Associates LLC owned 0.26% of Core Laboratories worth $1,501,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. AlphaQuest LLC boosted its holdings in Core Laboratories by 265,800.0% in the 1st quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company’s stock valued at $40,000 after purchasing an additional 2,658 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of Core Laboratories by 400.9% in the second quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock valued at $84,000 after buying an additional 5,869 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Core Laboratories by 160.8% in the second quarter. Assetmark Inc. now owns 7,530 shares of the oil and gas company’s stock valued at $87,000 after buying an additional 4,643 shares in the last quarter. Ingalls & Snyder LLC acquired a new position in Core Laboratories during the second quarter worth $115,000. Finally, Vanguard Personalized Indexing Management LLC purchased a new position in Core Laboratories in the second quarter worth $146,000. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Price Performance

Core Laboratories stock opened at $16.38 on Friday. The firm has a market capitalization of $762.61 million, a PE ratio of 24.45, a P/E/G ratio of 14.94 and a beta of 1.08. Core Laboratories Inc. has a 52 week low of $9.72 and a 52 week high of $20.82. The firm’s 50-day simple moving average is $15.69 and its 200 day simple moving average is $13.14. The company has a quick ratio of 1.76, a current ratio of 2.37 and a debt-to-equity ratio of 0.41.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, October 22nd. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. The company had revenue of $134.52 million during the quarter, compared to analysts’ expectations of $130.92 million. Core Laboratories had a net margin of 6.21% and a return on equity of 12.85%. The firm’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.25 earnings per share. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. On average, equities research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, November 24th. Shareholders of record on Monday, November 3rd were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Monday, November 3rd. Core Laboratories’s dividend payout ratio is 5.97%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Core Laboratories in a research note on Monday, December 22nd. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.